Artiva Biotherapeutics (ARTV) EPS (Basic) (2023 - 2026)

Artiva Biotherapeutics' (ARTV) quarterly EPS (Basic) came in at -$1.43 in Q1 2026, up 5.76% year-on-year from -$1.35 in Q1 2025, and down 64.59% on a QoQ basis from -$0.87 in Q4 2025.

Artiva Biotherapeutics (ARTV) EPS (Basic) (2023 - 2026) Analysis & Trends

Artiva Biotherapeutics (ARTV) has 4 years of EPS (Basic) data on file, last reported at -$1.43 in Q1 2026.

  • On a quarterly basis, EPS (Basic) rose 5.76% year-over-year to -$1.43 in Q1 2026; TTM through Mar 2026 was -$4.72, a 5.74% increase from a year earlier, with the FY2025 full-year figure at -$3.59, up 34.66% from the prior year.
  • EPS (Basic) for Q1 2026 stood at -$1.43, down from -$0.87 in the prior quarter.
  • Over the last five years, EPS (Basic) for ARTV reached as high as $13.92 in Q3 2023 and fell as low as -$34.58 in Q2 2024.
  • Historically, EPS (Basic) has averaged -$6.37 across 4 years, with a median of -$1.65 in 2024.
  • Across the five-year window, EPS (Basic) sank 144.78% in 2024 and soared 95.64% in 2025, its largest moves.
  • Year by year, EPS (Basic) stood at -$14.45 in 2023, then surged by 85.74% to -$2.06 in 2024, then jumped by 57.96% to -$0.87 in 2025, then plunged by 64.59% to -$1.43 in 2026.
  • Per Business Quant data, the three most recent EPS (Basic) figures were -$1.43 in Q1 2026, -$0.87 in Q4 2025, and -$0.95 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 0.00
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.16
4 NuCana 279.75 Bn 279.75 Bn - 0.00
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 4.06
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 6.99
7 Belite Bio 62.51 Bn 62.51 Bn - 0.00
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 7.59
9 Revolution Medicines 37.78 Bn 37.78 Bn - -2.29
10 Artiva Biotherapeutics 249.99 Mn 249.99 Mn - -1.43

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.43
Dec 31, 2025 -0.87
Sep 30, 2025 -0.95
Jun 30, 2025 -1.51
Mar 31, 2025 -1.51
Dec 31, 2024 -2.06
Sep 30, 2024 -1.79
Jun 30, 2024 -34.58
Mar 31, 2024 -17.09
Dec 31, 2023 -14.45
Sep 30, 2023 13.92
Jun 30, 2023 -14.13